Adipose tissue deficiency and chronic inflammation in diabetic Goto-Kakizaki rats

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Xue, Bai ^a   Sukumaran, Siddharth ^a   Nie, Jing ^a   Jusko, William J ^a   DuBois, Debra C ^a   Almon, Richard R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENERGY METABOLISM; EXPRESSED SEQUENCE TAG; FOOD INTAKE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GLUCOSE HOMEOSTASIS; GOTO KAKIZAKI RAT; HEMOGLOBIN BLOOD LEVEL; INSULIN RESISTANCE; LEUKOCYTE COUNT; LIPID ANALYSIS; LIPOGENESIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; RAT; AGE; ALGORITHM; ANIMAL; ATROPHY; BODY WEIGHT; CHRONIC DISEASE; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; INFLAMMATION; METABOLISM; MICROARRAY ANALYSIS; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR KYOTO RAT;

ANIMALIA; RATTUS;

ADIPOSE TISSUE; AGE FACTORS; ALGORITHMS; ANIMALS; ATROPHY; BODY WEIGHT; CHRONIC DISEASE; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION PROFILING; GROWTH AND DEVELOPMENT; INFLAMMATION; MALE; MICROARRAY ANALYSIS; ORGAN SIZE; RATS; RATS, INBRED WKY;

EID: 79952130515     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017386     Document Type: Article

References (57)

1. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403.
2. Surmi BK, Hasty AH, (2008) Macrophage infiltration into adipose tissue: initiation, propagation and remodeling. Future Lipidol 3: 545-556.
3. Brunetti P, (2007) The lean patient with type 2 diabetes: characteristics and therapy challenge. Int J Clin Pract Suppl pp. 3-9.
4. Demmer RT, Jacobs DR Jr, Desvarieux M, (2008) Periodontal disease and incident type 2 diabetes: results from the First National Health and Nutrition Examination Survey and its epidemiologic follow-up study. Diabetes Care 31: 1373-1379.
5. McNeely M, (2004) Case study: diabetes in a patient with cirrhosis. Clin Diabetes 22: 42-44.
6. Mealey BL, Rose LF, (2008) Diabetes mellitus and inflammatory periodontal diseases. Compend Contin Educ Dent 29: 402-408, 410, 412-403.
7. Moxley RT 3rd, Griggs RC, Goldblatt D, VanGelder V, Herr BE, et al. (1978) Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. J Clin Invest 62: 857-867.
8. Rana JS, Mittleman MA, Sheikh J, Hu FB, Manson JE, et al. (2004) Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 27: 2478-2484.
9. Tiengo A, Fadini GP, Avogaro A, (2008) The metabolic syndrome, diabetes and lung dysfunction. Diabetes Metab 34: 447-454.
10. Bahtiyar G, Shin JJ, Aytaman A, Sowers JR, McFarlane SI, (2004) Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights. Curr Diab Rep 4: 194-198.
11. Knobler H, Zhornicky T, Sandler A, Haran N, Ashur Y, et al. (2003) Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association. Am J Gastroenterol 98: 2751-2756.
12. Greenwood MR, Hirsch J, (1974) Postnatal development of adipocyte cellularity in the normal rat. J Lipid Res 15: 474-483.
13. Guilherme A, Virbasius JV, Puri V, Czech MP, (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367-377.
14. Goto Y, Suzuki K, Ono T, Sasaki M, Toyota T, (1988) Development of diabetes in the non-obese NIDDM rat (GK rat). Adv Exptl Med Biol 246: 29-31.
15. Portha B, (2005) Programmed disorders of B-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabet Metabol Res Rev 21: 495-504.
16. Almon RR, DuBois DC, Lai W, Xue B, Nie J, et al. (2009) Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats. J Endocrinol 200: 331-346.
17. Hazra A, Pyszczynski NA, DuBois DC, Almon RR, Jusko WJ, (2007) Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats. Pharm Res 25: 769-780.
18. Almon RR, DuBois DC, Jin JY, Jusko WJ, (2005) Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle. J Endocrinology 184: 219-232.
19. Almon RR, DuBois DC, Jusko WJ, (2007) A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens. Endocrinology 148: 2209-2225.
20. Almon RR, Yang E, Lai W, Androulakis IP, DuBois DC, et al. (2008) Circadian variations in rat liver gene expression: relationships to drug actions. J Pharmacol Exp Ther 326: 700-716.
21. Sukumaran S, Xue B, Jusko WJ, Dubois DC, Almon RR, (2010) Circadian variations in gene expression in rat abdominal adipose tissue and relationship to physiology. Physiol Genomics 42A: 141-152.
22. Benoit SC, Clegg DJ, Seeley RJ, Woods SC, (2004) Insulin and leptin as adiposity signals. Recent Prog Horm Res 59: 267-285.
23. Gale SM, Castracane D, Mantzoros CS, (2004) Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. J Nutr 134: 295-298.
24. Koerner A, Kratzch J, Kiess W, (2005) Adipocytokines: leptin- the classical, resistin- the controversial, adiponectin- the promising, and more to come. Best Pract Res Clin Endocrin Metabol 19: 525-546.
25. Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, et al. (2001) Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 288: 1102-1107.
26. Li Z, Soloski MJ, Diehl AM, (2005) Dietary factors alter hepatic innate immune system in mice with nonalcholic fatty liver disease. Hepatology 42: 880-885.
27. Mofredj A, Howaizi M, Grasset D, Licht H, Loison S, et al. (2002) Diabetes mellitus during interferon therapy for chronic viral hepatitis. Dig Dis Sci 47: 1649-1654.
28. Bomalaski JS, Baker DG, Brophy L, Resurreccion NV, Spilberg I, et al. (1989) A phospholipase A2-activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide, and eicosanoids. J Immunol 142: 3957-3962.
29. Nara N, Nakayama Y, Okamoto S, Tamura H, Kiyono M, et al. (2007) Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J Biol Chem 282: 30794-30803.
30. Cornish AL, Freeman S, Forbes G, Ni J, Zhang M, et al. (1998) Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. Blood 92: 2123-2132.
31. Nevalainen TJ, Haapamaki MM, Gronroos JM, (2000) Roles of secretory phospholipases A(2) in inflammatory diseases and trauma. Biochim Biophys Acta 1488: 83-90.
32. Ettinger RA, Moustakas AK, Lobaton SD, (2004) Open reading frame sequencing and structure-based alignment of polypeptides encoded by RT1-Bb, RT1-Ba, RT1-Db, and RT1-Da alleles. Immunogenetics 56: 585-596.
33. Ettinger RA, Papadopoulos GK, Moustakas AK, Nepom GT, Kwok WW, (2006) Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles. J Immunol 176: 1988-1998.
34. Ting JP, Trowsdale J, (2002) Genetic control of MHC class II expression. Cell 109 (Suppl): S21-33.
35. Fife KL, Liu Y, Schmelzer KR, Tsai HJ, Kim IH, et al. (2008) Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation. J Pharmacol Exp Ther 327: 707-715.
36. Baba M, Hong SB, Sharma N, Warren MB, Nickerson ML, et al. (2006) Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci U S A 103: 15552-15557.
37. Zhang BB, Zhou G, Li C, (2009) AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 9: 407-416.
38. Hurlin P, Steingrimsson E, Copeland N, Jenkins N, Eisenman R, (1999) Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. EMBO Journal 18: 7019-7028.
39. Hackl H, Burkard TR, Sturn A, Rubio R, Schleiffer A, et al. (2005) Molecular processes during fat cell development revealed by gene expression profiling and functional annotation. Genome Biol 6: R108.
40. Kano A, Wolfgang MJ, Gao Q, Jacoby J, Chai G, et al. (2003) Endothelial cells require STAT3 for protectin against endotoxin-induced inflammation. J Exp Med 198: 1517-1525.
41. Cernkovich ER, Deng J, Bond MC, Combs TP, Harp JB, (2008) Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology 149: 1581-1590.
42. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, et al. (2004) MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279: 52361-52365.
43. Landthaler M, Gaidatzis D, Rothballer A, Chen PY, Soll SJ, et al. (2008) Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. Rna 14: 2580-2596.
44. Inoue H, Kato R, Fukuyama S, Nonami A, Taniguchi K, et al. (2005) Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness. J Exp Med 201: 73-82.
45. Freytag SO, (1988) Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol Cell Biol 8: 1614-1624.
46. Barbu A, Hedlund GP, Lind J, Carlsson C, (2009) Pref-1 and adipokine expression in adipose tissues of GK and Zucker rats. Molecular and Cellular Endocrinology 299: 163-171.
47. Plachot C, Movassat J, Portha B, (2001) Impaired beta-cell regeneration after partial pancreatectomy in the adult Goto-Kakizaki rat, a spontaneous model of type II diabetes. Histochem Cell Biol 116: 131-139.
48. Lacasa D, Taleb S, Keophiphath M, Miranville A, Clement K, (2007) Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 148: 868-877.
49. Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES, et al. (1993) Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Frontiers in Neuroendocrinology 14: 303-347.
50. Yuan J, (1993) Modeling blood/plasma concentrations in dosed feed and dosed drinking water toxicology studies. Toxicol Appl Pharmacol 119: 131-141.
51. Wang T, Hung CCY, Randall DJ, (2006) The comparative physiology of food deprivation: from feast to famine. Annu Rev Physiol 68: 223-251.
52. Hanson RW, Reshef L, (2003) Glyceroneogenesis revisited. Biochimie 85: 1199-1205.
53. Sukumaran S, Almon RR, DuBois DC, Jusko WJ, (2010) Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action. Adv Drug Deliv Rev 62: 904-917.
54. Buren J, Lai YC, Lundgren M, Eriksson JW, Jensen J, (2008) Insulin action and signalling in fat and muscle from dexamethasone-treated rats. Arch Biochem Biophys 474: 91-101.
55. Qi D, Rodrigues B, (2007) Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. Am J Physiol Endocrinol Metab 292: E654-667.
56. Bach AG, Muhlbauer E, Peschke E, (2010) Adrenoceptor expression and diurnal rhythms of melatonin and its precursors in the pineal gland of type 2 diabetic goto-kakizaki rats. Endocrinology 151: 2483-2493.
57. Maekawa F, Fujiwara K, Kohno D, Kuramochi M, Kurita H, et al. (2006) Young adult-specific hyperphagia in diabetic Goto-Kakizaki rats is associated with leptin resistance and elevation of neuropeptide Y mRNA in the arcuate nucleus. J Neuroendocrinology 18: 748-756.